Merlin Neuroresearch G Limited - Period Ending 2018-01-31

MERLIN NEURORESEARCH G LTD. - Company Information

Merlin Neuroresearch G Limited 03301413 false 2017-02-01 2018-01-31 2018-01-31 The principal activity of the company is is now ceased and the company is dormant. Digita Accounts Production Advanced 6.21.8540.0 Software true 03301413 2017-02-01 2018-01-31 03301413 2018-01-31 03301413 core:CurrentFinancialInstruments core:WithinOneYear 2018-01-31 03301413 bus:Micro-entities 2017-02-01 2018-01-31 03301413 bus:AuditExemptWithAccountantsReport 2017-02-01 2018-01-31 03301413 bus:FullAccounts 2017-02-01 2018-01-31 03301413 bus:RegisteredOffice 2017-02-01 2018-01-31 03301413 bus:CompanySecretary1 2017-02-01 2018-01-31 03301413 bus:Director1 2017-02-01 2018-01-31 03301413 bus:PrivateLimitedCompanyLtd 2017-02-01 2018-01-31 03301413 countries:AllCountries 2017-02-01 2018-01-31 03301413 2017-01-31 03301413 core:CurrentFinancialInstruments core:WithinOneYear 2017-01-31 iso4217:GBP

Registration number: 03301413

Merlin Neuroresearch G Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 31 January 2018

Chartered Accountants

Merlin Neuroresearch G Limited

Contents

Company Information	1
Balance Sheet	2
Notes to the Financial Statements	3

Merlin Neuroresearch G Limited

Company Information

Director

Mr Richard Timothy Hanbury

Company secretary

Mrs Kathleen Hobbs

Registered office

Unity Chambers
34 High East Street
Dorchester
Dorset
DT1 1HA

Accountants

Edwards & Keeping
Chartered Accountants
Unity Chambers
34 High East Street
Dorchester
Dorset
DT1 1HA

- 1 -

Merlin Neuroresearch G Limited

(Registration number: 03301413)
Balance Sheet as at 31 January 2018

	Note	2018		2017
		£	£	£	£
Fixed assets			465		618
Creditors: Amounts falling due within one year			(120,317)		(120,016)
Total assets less current liabilities			(119,852)		(119,398)
Accruals and deferred income			(50)		(300)
			(119,902)		(119,698)
Capital and reserves			(119,902)		(119,698)

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

For the financial year ending 31 January 2018 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

Approved and authorised by the director on 31 October 2018

Mr Richard Timothy Hanbury
Director

- 2 -

Merlin Neuroresearch G Limited

Notes to the Financial Statements
for the Year Ended 31 January 2018

1	General information

The company is a private company limited by share capital, incorporated in UK.

The address of its registered office is:
Unity Chambers
34 High East Street
Dorchester
Dorset
DT1 1HA
United Kingdom

The principal place of business is:
32C Sutherland Street
London
SW1V 4JZ

These financial statements were authorised for issue by the director on 31 October 2018.

Basis of preparation

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

- 3 -